joshuawwang

@joshuawwang

Bio-Entrepreneur/ Founder of VerImmune & PathoVax LLC/Recovering Vaccine Scientist/ Airline miles fanatic/ tweets&views are my own / aka 王伟源

Boston & Baltimore
Vrijeme pridruživanja: srpanj 2014.

Tweetovi

Blokirali ste korisnika/cu @joshuawwang

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @joshuawwang

  1. proslijedio/la je Tweet

    Find out about the pipeline and market for tumour-agnostic therapies in this article published today by and colleagues

    Poništi
  2. proslijedio/la je Tweet

    It’s HPV Awareness Week! 9 out of 10 cases of cervical cancer could be prevented with HPV vaccination? Spread the word about the importance of vaccination for preventing cervical cancer – and the many other cancers caused by HPV.

    Poništi
  3. proslijedio/la je Tweet
    12. pro 2019.

    New review! The activation of bystander CD8+ T cells and their roles in viral .

    Poništi
  4. proslijedio/la je Tweet
    17. sij

    This week we're exploring the landscape of head and neck cancer, and upcoming challenges in cancer immunotherapy.

    Poništi
  5. 17. sij
    Poništi
  6. proslijedio/la je Tweet
    15. sij
    Poništi
  7. 16. sij

    There’s no silver bullet against cancer, looking forward to seeing more targets against this horrible disease!

    Poništi
  8. 15. sij
    Poništi
  9. proslijedio/la je Tweet
    15. sij

    Come learn about how we intend to repurpose our immune memory against childhood vaccines or past infections against cancer at the today! Wed, Jan 15, 2020 at 10:30 a.m. PST Yosemite A (Ballroom Level)

    Poništi
  10. proslijedio/la je Tweet
    15. sij

    Check out this superb review on the top 10 challenges in cancer by

    Poništi
  11. proslijedio/la je Tweet
    14. sij

    Featured article this month is the Perspective from & Priti Hegde: "Top 10 Challenges in " | Discusses the top 10 challenges facing this field & what is necessary to overcome them

    Poništi
  12. proslijedio/la je Tweet
    14. sij

    Our website is up! Come learn more about Anti-tumor Immune Redirection on Wed, Jan 15, 2020 at 10:30 a.m. PST at the Yosemite A (Ballroom Level) !

    Poništi
  13. 14. sij

    VerImmune is an immune oncology company focused on developing a virally-inspired platform that redirects pre-existing Immune memory from past infections or childhood vaccines to target cancer. Today at we announce the expansion of our Board & Leadership team!

    Poništi
  14. proslijedio/la je Tweet
    11. sij

    cell # going down after the infusion? followed by as a smart combo by researcher An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors

    Poništi
  15. proslijedio/la je Tweet
    29. pro 2019.

    ICYMI: it’s almost 2020... so here’s our 2019 Year In Review to fill up some idle holiday time!

    Poništi
  16. 31. pro 2019.

    Great paper by & colleagues further demonstrating the concept of repurposing vaccines against pathogens as drugs for immunotherapy! Exciting times in 2020 await

    Poništi
  17. proslijedio/la je Tweet
    27. pro 2019.

    Comment: Viruses could hold solutions to many of humanity’s current problems. Tapping into the benefits and threats requires comprehensive classification of the entire virosphere, urges Jens H. Kuhn and colleagues.

    Poništi
  18. 26. pro 2019.

    Great tweet-torial on from one of the most amazing leaders in the field of Pancratic cancer. Much progress has been made in the past decade, looking forward to more applicable translations from these numerous findings.

    Poništi
  19. proslijedio/la je Tweet

    From the December issue - a perspective on expanding the toolbox for targeted protein degradation

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·